Clinical Trials List
2021-11-01 - 2030-12-01
Phase III
Recruiting7
ICD-10C90.00
Multiple myeloma not having achieved remission
ICD-10C90.02
Multiple myeloma in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9203.00
Multiple myeloma, without mention of remission
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- MING YAO Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- 劉家豪 Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- 柯紀綸 Division of Nuclear Medicine
- - - Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Chung Kao Division of Hematology & Oncology
- HSUAN JEN SHIH Division of Hematology & Oncology
- Po-Nan Wang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jyh-Pyng Gau Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
- 蔡淳光 Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Ting-An Lin Division of Hematology & Oncology
- Sheng-Hsuan Chien Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- Jiun-I Lai Division of Radiation Therapy
- Yao-Chung Liu Division of Hematology & Oncology
- 陳玟均 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu Division of General Internal Medicine
- Ya-Ping Chen Division of General Internal Medicine
- Chun-Hui Lee Division of General Internal Medicine
- Sin-Syue Li Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHENG-HSIEN LIN Division of Hematology & Oncology
- PO-WEI LIAO Division of Hematology & Oncology
- Tsung -Chih Chen Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- Chieh-Lin Teng Division of Hematology & Oncology
- YU-HSUAN SHIH Division of Hematology & Oncology
- 蔡昇亨 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
864 participants
